+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Disease Vaccine Market by Vaccine Type, Age Group, Distribution Channel, End User, Route Of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012369
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory disease vaccine market is undergoing rapid transformation, shaped by scientific advancement, regulatory evolution, and pressing public health needs. Senior executives, policymakers, and industry strategists are seeking actionable intelligence as innovation, market entry dynamics, and risk mitigation become increasingly complex in an interconnected global environment.

Market Snapshot: Respiratory Disease Vaccine Market

The Respiratory Disease Vaccine Market grew from USD 24.78 billion in 2024 to USD 26.28 billion in 2025. It is projected to maintain strong momentum at a CAGR of 5.89%, reaching USD 34.95 billion by 2030. This growth trajectory reflects not only the continued impact of global health challenges but also the industry’s ability to scale cutting-edge immunization technologies and adapt to shifting policy frameworks.

Scope & Segmentation

  • Vaccine Types: Conjugate, inactivated, live attenuated, mRNA, subunit, and viral vector vaccines support diverse immunization needs and advance preventive medicine.
  • Age Groups: Adult (including middle-aged, older adults, and young adults), geriatric (senior and elderly), and pediatric (adolescent, child, infant, and toddler) segments define differentiated development priorities with unique immunogenic profiles and program logistics.
  • Distribution Channels: Direct purchase, hospital pharmacy, online pharmacy (including mobile app and website sales), and retail pharmacy (spanning chain and independent outlets) provide multiple market entry and scaling opportunities.
  • End Users: Clinics, home care, hospitals (government and private), and research institutes each contribute to a robust landscape demanding flexible delivery and compliance.
  • Routes of Administration: Intramuscular, intranasal, oral, and subcutaneous modalities create distinct pathways for patient experience and operational efficiency.
  • Geographic Coverage:
    • Americas (including United States regions, Canada, Mexico, Brazil, Argentina)
    • Europe, Middle East & Africa (including major European economies, Middle East states, and African growth markets)
    • Asia-Pacific (covering key hubs in China, India, Japan, Australia, South Korea, Southeast Asia, and others)
  • Leading Companies: Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Seqirus Pty Ltd, Moderna Inc., AstraZeneca plc, Johnson & Johnson, Novavax Inc., BioNTech SE, and Sinovac Biotech Co., Ltd.

Key Takeaways

  • Regulatory agility, including adaptive approval pathways, is accelerating vaccine availability and enabling timely responses to emerging variants.
  • Conjugate, subunit, and mRNA vaccine platforms are driving innovations that improve adaptability, safety, and scale, transforming both established and novel immunization strategies.
  • Segmented immunization programs, tailored by demographic needs—such as geriatric, pediatric, and occupational groups—are critical to maximizing public health returns and market impact.
  • Diversified channels, including digital and institutional routes, support expanded reach, especially as online and retail pharmacies increase accessibility to vaccines for targeted populations.
  • Strategic partnerships are fostering local manufacturing and resilient supply chains, helping stakeholders manage volatility in procurement and logistics.
  • Regional alliances, particularly in Asia-Pacific and EMEA, are boosting cross-border distribution and promoting equitable access through public-private collaboration and infrastructure investment.

Tariff Impact

Recent tariff policies imposed in 2025 have reshaped sourcing and manufacturing strategies. Duties on imported raw materials and components are prompting vaccine developers to invest in domestic capacity, reduce offshore dependencies, and form new alliances with U.S.-based partners. This shift influences procurement decisions, favoring manufacturers with end-to-end, vertically integrated operations. While short-term margin pressures remain, the move toward local production is enhancing supply chain transparency and contributing to long-term resilience.

Methodology & Data Sources

This analysis deploys a rigorous, multi-source research approach, combining primary interviews with leading vaccine developers, regulatory experts, and distribution professionals. Peer-reviewed studies, regulatory filings, and comprehensive databases inform both quantitative assessments of tariff and supply chain impacts and nuanced qualitative scenario planning. Findings are validated through cross-checks and reviewed by subject-matter experts to preserve objectivity.

Why This Report Matters

  • Empowers executive decision-making by delivering strategically relevant insights into market segmentation, competitive strategy, and regulatory adaptation.
  • Facilitates risk mitigation through in-depth analysis of supply chain and policy shifts, including the influence of tariffs and regional disruptions.
  • Supports commercialization and partnership strategies by clarifying where demographic and regional opportunities align with technological advances.

Conclusion

The respiratory disease vaccine market presents both complex challenges and transformative potential. Informed strategy, adaptive operations, and collaborative innovation will define future leaders as the sector evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Disease Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Conjugate Vaccine
8.3. Inactivated Vaccine
8.4. Live Attenuated Vaccine
8.5. MRNA Vaccine
8.6. Subunit Vaccine
8.7. Viral Vector Vaccine
9. Respiratory Disease Vaccine Market, by Age Group
9.1. Introduction
9.2. Adult
9.2.1. Middle Aged
9.2.2. Older Adult
9.2.3. Young Adult
9.3. Geriatric
9.3.1. Elderly
9.3.2. Senior
9.4. Pediatric
9.4.1. Adolescent
9.4.2. Child
9.4.3. Infant
9.4.4. Toddler
10. Respiratory Disease Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Direct Purchase
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.4.1. Mobile App Sales
10.4.2. Website Sales
10.5. Retail Pharmacy
10.5.1. Chain Pharmacy
10.5.2. Independent Pharmacy
11. Respiratory Disease Vaccine Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. Government Hospitals
11.4.2. Private Hospitals
11.5. Research Institutes
12. Respiratory Disease Vaccine Market, by Route Of Administration
12.1. Introduction
12.2. Intramuscular
12.3. Intranasal
12.4. Oral
12.5. Subcutaneous
13. Americas Respiratory Disease Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Respiratory Disease Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Respiratory Disease Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. GlaxoSmithKline plc
16.3.3. Sanofi S.A.
16.3.4. Seqirus Pty Ltd
16.3.5. Moderna, Inc.
16.3.6. AstraZeneca plc
16.3.7. Johnson & Johnson
16.3.8. Novavax, Inc.
16.3.9. BioNTech SE
16.3.10. Sinovac Biotech Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RESPIRATORY DISEASE VACCINE MARKET MULTI-CURRENCY
FIGURE 2. RESPIRATORY DISEASE VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. RESPIRATORY DISEASE VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RESPIRATORY DISEASE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RESPIRATORY DISEASE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RESPIRATORY DISEASE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VECTOR VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY OLDER ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TODDLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MOBILE APP SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY WEBSITE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 80. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 81. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 82. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 85. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 91. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 92. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 93. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 145. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 147. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 148. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 149. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 158. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 159. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 160. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 178. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 180. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 181. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 182. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 184. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 185. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 191. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 192. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 193. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 196. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 235. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 236. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 237. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 239. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 240. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 255. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 257. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 258. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 259. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 261. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 262. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 266. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 268. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 269. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 270. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 272. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 273. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 299. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 301. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 302. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 303. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 305. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 306. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 308. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 310. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 311. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 312. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 313. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 314. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 316. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 317. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Respiratory Disease Vaccine market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus Pty Ltd
  • Moderna, Inc.
  • AstraZeneca plc
  • Johnson & Johnson
  • Novavax, Inc.
  • BioNTech SE
  • Sinovac Biotech Co., Ltd.

Table Information